Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-21

Clinical Trial Update: Effects of TNF Blockade on Human BPH/LUTS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of tumor necrosis factor blockade on Benign Prostatic Hyperplasia and related lower urinary tract symptoms; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF inhibitor (tumor necrosis factor inhibitor)

Snippet

Sponsor: Endeavor Health | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 2 | Status: RECRUITING